BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37491482)

  • 21. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
    Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM
    Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data.
    Rana S; Valbuena GN; Curry E; Bevan CL; Keun HC
    Br J Cancer; 2022 Feb; 126(3):502-513. PubMed ID: 35022525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potential microRNA diagnostic panels and uncovering regulatory mechanisms in breast cancer pathogenesis.
    Sharifi Z; Talkhabi M; Taleahmad S
    Sci Rep; 2022 Nov; 12(1):20135. PubMed ID: 36418345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer.
    Wen Z; Huang G; Lai Y; Xiao L; Peng X; Liu K; Zhang C; Chen X; Li R; Li X; Lai Y; Ni L
    Clin Transl Oncol; 2022 May; 24(5):909-918. PubMed ID: 35028929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients.
    Khalighfard S; Alizadeh AM; Irani S; Omranipour R
    Sci Rep; 2018 Dec; 8(1):17981. PubMed ID: 30568292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer.
    Yong FL; Law CW; Wang CW
    BMC Cancer; 2013 Jun; 13():280. PubMed ID: 23758639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles.
    Elias K; Smyczynska U; Stawiski K; Nowicka Z; Webber J; Kaplan J; Landen C; Lubinski J; Mukhopadhyay A; Chakraborty D; Connolly DC; Symecko H; Domchek SM; Garber JE; Konstantinopoulos P; Fendler W; Chowdhury D
    Nat Commun; 2023 Jun; 14(1):3350. PubMed ID: 37291133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a six-microRNA signature as a potential diagnostic biomarker in breast cancer tissues.
    Mahmoudian M; Razmara E; Mahmud Hussen B; Simiyari M; Lotfizadeh N; Motaghed H; Khazraei Monfared A; Montazeri M; Babashah S
    J Clin Lab Anal; 2021 Nov; 35(11):e24010. PubMed ID: 34528314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
    Lee IH; Kim G; Kwak SG; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Hur K; Kim JG
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel panel of blood-based microRNAs capable of discrimination between benign breast disease and breast cancer at early stages.
    Sadeghi H; Kamal A; Ahmadi M; Najafi H; Sharifi Zarchi A; Haddad P; Shayestehpour B; Kamkar L; Salamati M; Geranpayeh L; Lashkari M; Totonchi M
    RNA Biol; 2021 Nov; 18(sup2):747-756. PubMed ID: 34793290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies.
    García-Giménez JL; García-Trevijano ER; Avilés-Alía AI; Ibañez-Cabellos JS; Bovea-Marco M; Bas T; Pallardó FV; Viña JR; Zaragozá R
    Orphanet J Rare Dis; 2022 Dec; 17(1):450. PubMed ID: 36575500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of microRNA expression profile with clinical response to tumor necrosis factor inhibitor in treating rheumatoid arthritis patients: A prospective cohort study.
    Liu Y; Han Y; Qu H; Fang J; Ye M; Yin W
    J Clin Lab Anal; 2019 Sep; 33(7):e22953. PubMed ID: 31245894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
    Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
    Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of circulating microRNAs miR-142-3p and miR-598-3p in women with polycystic ovary syndrome as potential diagnostic markers.
    Insenser M; Quintero A; de Lope S; Álvarez-Blasco F; Martínez-García MÁ; Luque-Ramírez M; Escobar-Morreale HF
    Hum Reprod; 2023 May; 38(5):951-960. PubMed ID: 36931262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of circulating microRNA specific for patients with familial adenomatous polyposis.
    Yamano T; Kubo S; Sonoda E; Kominato T; Kimura K; Yasuhara M; Kataoka K; Son J; Babaya A; Takenaka Y; Matsubara T; Beppu N; Ikeda M
    PLoS One; 2021; 16(5):e0250072. PubMed ID: 33945535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia.
    Rzepiel A; Kutszegi N; Gézsi A; Sági JC; Egyed B; Péter G; Butz H; Nyírő G; Müller J; Kovács GT; Szalai C; Semsei ÁF; Erdélyi DJ
    J Transl Med; 2019 Nov; 17(1):372. PubMed ID: 31727091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome-A Pilot Study.
    Sievänen T; Jokela T; Hyvärinen M; Korhonen TM; Pylvänäinen K; Mecklin JP; Karvanen J; Sillanpää E; Seppälä TT; Laakkonen EK
    Cancer Prev Res (Phila); 2024 Jun; 17(6):243-254. PubMed ID: 38551987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.